CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenues	$ 5,242,579	$ 5,048,065	$ 14,388,123	$ 16,020,327
Cost of Goods Sold	3,383,842	3,311,967	9,614,799	10,045,316
Gross Profit	1,858,737	1,736,098	4,773,324	5,975,011
Research and Development Expenses	192,773	206,375	627,259	660,518
Selling, General and Administrative Expenses	1,924,491	2,022,991	5,514,047	5,338,498
Total Operating Expenses	2,117,264	2,229,366	6,141,306	5,999,016
Operating Loss	(258,527)	(493,268)	(1,367,982)	(24,005)
Interest Expense	(58,528)	(48,124)	(172,290)	(167,443)
Gain on Revaluation of Contingent Liability	0	142,960	0	142,960
Net Loss	$ (317,055)	$ (398,432)	$ (1,540,272)	$ (48,488)
Loss Per Share:
Loss Per Share, Basic	$ (0.05)	$ (0.07)	$ (0.25)	$ (0.01)
Loss Per Share, Fully Diluted	$ (0.05)	$ (0.07)	$ (0.25)	$ (0.01)
Weighted Average Common Shares Outstanding:
Weighted Average Common Shares Outstanding, Basic	6,068,419	5,640,473	6,067,165	5,639,015
Weighted Average Common Shares Outstanding, Fully Diluted	6,068,419	5,640,473	6,067,165	5,639,015